The development of drugs that target chloride channels has lagged behind those of other targets, partly because of technical challenges in screening for chloride-channel modulators. This Review examines the methods for assaying chloride-channel function and emerging drug development opportunities for each of the chloride-channel classes.
- Alan S. Verkman
- Luis J. V. Galietta